ASSET ACQUISITION (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended		6 Months Ended
	May 18, 2026	Mar. 25, 2026	Jun. 30, 2026	Jun. 30, 2025
Asset Acquisition [Line Items]
Amortization expense			$ 93	$ 0
Asset Acquisition Of Oratech Pharmaceuticals Ltd [Member] | Share Purchase Agreement [Member]
Asset Acquisition [Line Items]
Number of shares issued		1,250,363
Warrants to purchase ordinary shares		1,006,113
Asset Acquisition Of Oratech Pharmaceuticals Ltd [Member] | Share Purchase Agreement [Member] | Warrant [Member]
Asset Acquisition [Line Items]
Number of shares issued		1,296,296
Per share price of shares issued		$ 5.4
Asset Acquisition Of Oratech Pharmaceuticals Ltd [Member] | Share Purchase Agreement [Member]
Asset Acquisition [Line Items]
Consideration transferred		$ 12,422
Cash payment		6,500
Prepaid clinical trial services asset		975
Consideration transferred of intellectual property		$ 5,900
Asset Acquisition Of Skelable Acquisition [Member]
Asset Acquisition [Line Items]
Consideration transferred	$ 442
Cash payment	20
Contingent consideration upon achievement of milestone	$ 250
Estimated Useful Life (Years)			5 years
Amortization expense			$ 10
Asset Acquisition Of Skelable Acquisition [Member] | Ordinary Share [Member]
Asset Acquisition [Line Items]
Number of stocks issued for acquisitions	34,328